🇫🇷
France · FR · FR:60133973
TAMSULOSINE ZYDUS FRANCE LP 0,4 mg, gélule à libération prolongée
ReimbursedATC G04CA02
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerZYDUS FRANCE
CountryFR (France)
ATC codeG04CA02
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400937186209plaquette(s) PVC polyéthylène PVDC aluminium de 30 gélule(s)EUR 4.52
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "60133973",
"date_amm": "2006-01-16",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code G04CA02.
- PLAdatamAdamed Pharma S.A.
- PLAdatam XRAdamed Pharma S.A.
- GBAlphacard MR 400microgram capsulesRatiopharm UK Ltd
- 🇮🇹ANTUNES*20 cps 0,4 mg rilascio modificatoSO.SE.PHARM Srl
- 🇮🇹ANTUNES*30 cps 0,4 mg rilascio modificatoSO.SE.PHARM Srl
- PLApo-TamisAurovitas Pharma Polska Sp. z o.o.
- CAAPO-TAMSULOSIN CRAPOTEX INC
- CAAURO-TAMSULOSIN CRAURO PHARMA INC
Access this data programmatically
Query TAMSULOSINE ZYDUS FRANCE LP 0,4 mg, gélule à libération prolongée and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.